Rivaroxaban Impurity N19 CAS 241483-00-1
| CAS No. | 241483-00-1 |
| Molecular Formula | C9H14N4O3 |
| Molecular Weight | 226.23 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Rivaroxaban Impurity N19 is closely related to an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
As a process- or degradation-related impurity, Rivaroxaban Impurity N19 (CAS 241483-00-1, C9H14N4O3) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Rivaroxaban Impurity N19 (C9H14N4O3) contains an amino-acid-derived structure, an amide group, a hydroxyl group, an ether linkage. It is notably hygroscopic, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Rivaroxaban Impurity N19 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C9H14N4O3 |
| Molecular Weight | 226.23 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (faint amine-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, ethanol, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 5.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 2025 |
| Nitrogen Atoms | 4 |
Related Rivaroxaban Standards
- Rivaroxaban Impurity 37 (CAS 446292-04-2)
- Rivaroxaban Impurity 58 (CAS 845729-43-3)
- Rivaroxaban Impurity 59 (CAS 845729-41-1)
- Rivaroxaban Impurity 213 (CAS CATO-C4X-1090213)
- Rivaroxaban Impurity 133 (CAS 130155-41-8)
- Rivaroxaban Impurity 7 (CAS 186348-58-3)
- Rivaroxaban Impurity 110 (CAS CATO-C4X-1090110)
- Rivaroxaban Impurity 113 (CAS 119835-88-0)
Recommended Standards
- Genipin (CAS 6902-77-8)
- H-Ala-His-OH (CAS 3253-17-6)
- Flurenol (CAS 467-69-6)
- H-His-Ala-OH (CAS 16874-75-2)
- Osimertinib Impurity 56 (CAS CATO-C4X-204556)
- Brexpiprazole Impurity 35 (CAS 2143944-65-2)
- Cetirizine Impurity 63 DiHCl (CAS CATO-C4X-108363)
- 4-(2,6-Dimethylphenyl)-5-methyl-2-(3-(trifluoromethyl)benzyl)-2,4-dihydro-3H-1,2,4-triazol-3-one (CAS 860789-48-6)
- 1-[1-methyl-6-(piperazin-1-yl)-1H-indol-4-yl]-1,3-diazinane-2,4-dione (CAS 2766179-12-6)
- piperidin-2-ylmethyl N-cyclopentylcarbamate hydrochloride (CAS 1803571-17-6)
- 4-Nitro-5-propyl-1H-pyrazole-3-carboxamide (CAS 139756-08-4)
- 3-(4-Amino-5-oxo-3-thioxo-2,3,4,5-tetrahydro-1,2,4-triazin-6-yl)propanoic acid (CAS 84424-74-8)
- N-(((Propylthio)carbonyl)oxy)-2-(quinolin-8-yloxy)acetimidamide (CAS 88758-85-4)
- Peptide T (CAS 106362-32-7)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com